CONCOMITANT PATHOLOGY IN PATIENTS WITH BRONCHIAL ASTHMA

Authors

  • Yu. Feshchenko "National Institute of Tuberculosis and Pulmonology Named After F. G. Yanovsky National Academy of Medical Sciences of Ukraine”
  • I. Ilyinskaya "National Institute of Tuberculosis and Pulmonology Named After F. G. Yanovsky National Academy of Medical Sciences of Ukraine”
  • L. Arefyeva "National Institute of Tuberculosis and Pulmonology Named After F. G. Yanovsky National Academy of Medical Sciences of Ukraine”
  • L. Kurik "National Institute of Tuberculosis and Pulmonology Named After F. G. Yanovsky National Academy of Medical Sciences of Ukraine”
  • I. Turchina "National Institute of Tuberculosis and Pulmonology Named After F. G. Yanovsky National Academy of Medical Sciences of Ukraine”
  • A. Kanarsky "National Institute of Tuberculosis and Pulmonology Named After F. G. Yanovsky National Academy of Medical Sciences of Ukraine”

DOI:

https://doi.org/10.31618/ESSA.2782-1994.2021.2.73.122

Keywords:

bronchial asthma, comorbidities, allergies

Abstract

The discrepancy between the data of different authors on the prevalence of comorbidity pathology in patients with bronchial asthma, in particular the digestive organs, and the impact of comorbidities during asthma has led to the feasibility of this study.

References

Alekseev VV i dr. Medicinskie laboratornye tehnologii: rukovodstvo po klinicheskoj laboratornoj diagnostike. 2012;1:472.

Borovik IO ta in. Osoblivosti likuvannya bronhialnoyi astmi v poyednanni z gastroezofagealnoyu reflyuksnoyu hvoroboyu. Gastroenterologiya. 2014; 1(51):18–21. Rezhim dostupu: https://cyberleninka.ru/article/n/osoblivostilikuvannya-bronhialnoyi-astmi-v-poednanni-zgastroezofagealnoyu-reflyuksnoyu-hvoroboyu (data zvernennya: 4.03.2020).

Galimova ES i dr. Zabolevaniya organov pishevareniya u bolnyh bronhialnoj astmoj. Uspehi sovremennogo estestvoznaniya. 2010;1: 36−40.

Dudka TV, Huhlina OS, Dudka IV. Klinichni ta patogenetichni osoblivosti poyednanogo perebigu hronichnogo holecistitu iz bronhialnoyu astmoyu i hronichnim obstruktivnim zahvoryuvannyam legen, shlyahi medikamentoznoyi korekciyi. Visnik VDNZU «Ukrayinska medichna stomatologichna akademiya». 2013;13:2(42): 95-99.

Ermolkevich RF, Lapickij DV, Metelskij SM. Obostrenie bronhialnoj astmy: podhody k diagnostike i lecheniyu. Voennaya medicina. 2011:1. Rezhim dostupu:

https://www.mil.by/ru/smi/medicine_magazine/365/ (data zvernennya: 12.02.2020).

Lapach SN., Chubenko AV., Babich PN. Statisticheskie metody v mediko-biologicheskih issledovaniyah s ispolzovaniem Excel. K.: MORION, 2000. 320 s.

Nenasheva NM. Obostrenie bronhialnoj astmy: lechenie i profilaktika. RMZh. 2013;29:1490. Rezhim dostupu: https://www.rmj.ru/articles/lezni_dykhatelnykh_putey/Obostrenie_bronhi alynoy_astmy_lechenie_i_profilaktika/ (data zvernennya: 22.02.2020).

Popadinec IR. Kliniko-imunologichna efektivnist zastosuvannya karsetinu u hvorih na bronhialnu astmu z suputnoyu gastroezofagalnoyu reflyuksnoyu hvoroboyu. Visnik VDNZU «Ukrayinska medichna stomatologichna akademiya». 2013;13;3(43): 229–233. Rezhim dostupu: https://cyberleninka.ru/article/n/klinikoimunologichna-efektivnist-zastosuvannya-kvertsetinuu-hvorih-na-bronhialnu-astmu-z-suputnoyugastroezofagealnoyu-reflyuksnoyu (data zvernennya: 4.03.2020).

Solona OG, Pobedonna GP. Deyaki aspekti zastosuvannya tiotriazolinu u hvorih na bronhialnu astmu u poyednanni z hronichnim nekalkuloznim holecistitom. Astma ta alergiya. 2010;3(4):30–32. Rezhim dostupu: http://www.ifp.kiev.ua/doc/journals/aa/10/pdf10-34/30.pdf. (data zvernennya: 12.02.2020).

Feshenko YuI ta in. Adaptovana klinichna nastanova, zasnovana na dokazah: bronhialna astma (Chastina 1). Astma ta alergiya. 2020;2:5–26. DOI: https://doi.org/10.31655/2307-3373-2020-2-5-26.

Chumak YuYu. Sovremennye napravleniya v lechenii bolnyh bronhialnoj astmoj s komorbidnymi sostoyaniyami. Problemy ekologicheskoj i medicinskoj genetiki i klinicheskoj immunologoii. 2013;19(5): 349–357. Rezhim dostupu: http://ecoproblemlug.ucoz.ua/5_119/349-358.pdf (data zvernennya: 5.03.2020).

Castillo JR., Peters SP., Busse WW. Asthma Exacerbations: Pathogenesis, Prevention, and Treatment. J. Allergy Clin. Immunol. Pract. 2017;5(4): 918–927. DOI: https://doi.org/10.1016/j.jaip.2017.05.001 (data zvernennya: 12.02.2020).

Cazzola M. et al. Comorbidities of asthma: current knowledge and future research needs. Curr. Opin. Pulm. Med. 2013.19(1):36–41. Rezhim dostupu: https://www.ncbi.nlm.nih.gov/ pubmed/23114561 (data zvernennya: 09.03.2020).

Denlinger LC et al. Exacerbation-Prone Asthma. J. Allergy Clin. Immunol. Pract. 2019. 11: 2213−2219. Rezhim dostupu: https://pubmed.ncbi.nlm.nih.gov/31765853/ (data zvernennya: 16.02.2020).

Maselli DJ, Peters L. Medication Regimens for Managing Acute Asthma. Resp. Care. 2018; 6:783−796. Rezhim dostupu: http://rc.rcjournal.com/content/63/6/783 (data zvernennya: 17.02.2020).

Downloads

Published

2021-10-10

Issue

Vol. 2 No. 9(73) (2021)

Section

Статьи

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

CC BY-ND

A work licensed in this way allows the following:

1. The freedom to use and perform the work: The licensee must be allowed to make any use, private or public, of the work.

2. The freedom to study the work and apply the information: The licensee must be allowed to examine the work and to use the knowledge gained from the work in any way. The license may not, for example, restrict "reverse engineering."

2. The freedom to redistribute copies: Copies may be sold, swapped or given away for free, in the same form as the original.